One of Alfaisal College of Medicine research teams (Dr Ahmad Aljada, Dr Hanaa Hajeer and Dr Rajaa Fakhoury) has been recently accepted into the Panacea OncoStars 19/20 Action initiative, sponsored by Cancer Research UK. This is billed as an engagement, training and translation platform for researchers working in the field of oncology. The team was invited to attend a series of workshops, seminars & mentoring sessions to support the commercial development of their idea regarding the diagnostic value of LMNA/C transcript variants as cancer biomarkers and development of chemotherapeutic sensitizer. The team will be competing for a prize worth £100K.